The Role of L-arginine in Polycystic Ovary Syndrome
Status:
COMPLETED
Trial end date:
2025-07-04
Target enrollment:
Participant gender:
Summary
PCOS patients meeting the trial criteria were enrolled from the Shanghai 10th People's Hospital. The contents of this study were introduced to them, and they were invited to participate in the study. We further evaluated the efficacy and safety of arginine in treating PCOS by implementing the L-arginine clinical intervention protocol, and conducting post-intervention follow-up, efficacy evaluation, laboratory tests, and fecal sample 16S rRNA sequencing.